Verizon customers get home security with home internet
New Home Internet customers will receive a complimentary SimpliSafe bundle worth up to $400 BASKING…
New Home Internet customers will receive a complimentary SimpliSafe bundle worth up to $400 BASKING…
All summer long, take advantage of cost savings and perks on the network more people…
Solution improves the customer experience, reduces contact center costs, and is compatible with Google Cloud…
New AI Service Automatically Summarizes Every Call and Chat for Contact Centers to Reduce Handle…
Vancouver, British Columbia–(Newsfile Corp. – May 26, 2022) – NetCents Technology Inc. (CSE: NC) (FSE:…
Vancouver, British Columbia–(Newsfile Corp. – May 26, 2022) – Infinity Stone Ventures Corp. (CSE: GEMS)…
SAN FRANCISCO–(BUSINESS WIRE)–#SPAs—Enable, the leading cloud-based software solution for B2B rebate management, announces the release…
Premier event for accounting and finance professionals to be held June 6-9 in Las Vegas…
Limited number of event tickets to go on sale May 26 BOSTON–(BUSINESS WIRE)–#AI–Hack/Reduce, a non-profit…
DUBLIN–(BUSINESS WIRE)–The “Procurement As A Service Market Size, Share & Trends Analysis Report by Vertical…
Latest award recognizes Insight’s assistance in fueling Intel’s strong growth in the cloud space CHANDLER,…
Meeting to highlight updated data from the Phase 1/2a study of CLN-081 CAMBRIDGE, Mass., May…
Novel galectin-3-based mechanism of PD-1/PD-L1 checkpoint inhibitor resistance identified Galecto’s oral galectin-3 inhibitor candidate, GB1211,…
VANCOUVER, British Columbia, May 26, 2022 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV, the…
Ethics Committee approval received from the two sites that will conduct the SCI-110 trial in…
– Overall Response Rate of 7.7 percent is similar to checkpoint inhibitors alone – –…
CAMBRIDGE, Mass., May 26, 2022 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage…
Company to highlight novel multi-disciplinary approach to reverse the progression of both rare and common…
Phase 1 study evaluates safety, tolerability, pharmacokinetics and preliminary anti-tumor activity of YL-13027, an inhibitor…
SEATTLE and VANCOUVER, British Columbia, May 26, 2022 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc….